Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates

Richard Karlsson, Pradeep Chopra, Apoorva Joshi, Zhang Yang, Sergey Y Vakhrushev, Thomas Mandel Clausen, Chelsea D Painter, Gergo P Szekeres, Yen-Hsi Chen, Daniel R Sandoval, Lars Hansen, Jeffrey D Esko, Kevin Pagel, Douglas P Dyer, Jeremy E Turnbull, Henrik Clausen, Geert-Jan Boons, Rebecca L Miller

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Heparan sulfate (HS) polysaccharides are master regulators of diverse biological processes via sulfated motifs that can recruit specific proteins. 3-O-sulfation of HS/heparin is crucial for anticoagulant activity, but despite emerging evidence for roles in many other functions, a lack of tools for deciphering structure-function relationships has hampered advances. Here, we describe an approach integrating synthesis of 3-O-sulfated standards, comprehensive HS disaccharide profiling, and cell engineering to address this deficiency. Its application revealed previously unseen differences in 3-O-sulfated profiles of clinical heparins and 3-O-sulfotransferase (HS3ST)–specific variations in cell surface HS profiles. The latter correlated with functional differences in anticoagulant activity and binding to platelet factor 4 (PF4), which underlies heparin-induced thrombocytopenia, a known side effect of heparin. Unexpectedly, cells expressing the HS3ST4 isoenzyme generated HS with potent anticoagulant activity but weak PF4 binding. The data provide new insights into 3-O-sulfate structure-function and demonstrate proof of concept for tailored cell-based synthesis of next-generation heparins.

Original languageEnglish
Article numbereabl6026
Pages (from-to)1-14
JournalScience advances
Volume7
Issue number52
DOIs
Publication statusPublished - 22 Dec 2021

Fingerprint

Dive into the research topics of 'Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates'. Together they form a unique fingerprint.

Cite this